LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Price to Sales (2025 - 2026)

Updated

LENZ Therapeutics' Price to Sales was 9.76 in Q3 2026, down 87.2% from 76.09 a year earlier but up 17.5% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Price to Sales at LENZ Therapeutics came in at 26.27.

  • In earlier years, Price to Sales was 19.34 in FY2022.
  • Quarterly Price to Sales has moved between 8.31 (Q2 2026) and 167.07 (Q2 2025) over five years.
  • Per Business Quant data, LENZ's Price to Sales in the three quarters before Q3 2026 was 8.31 (Q2 2026), 13.67 (Q1 2026) and 26.27 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.76
Jun 30, 2026 8.31
Mar 31, 2026 13.67
Dec 31, 2025 26.27
Sep 30, 2025 76.09
Jun 30, 2025 167.07
API Access

LENZ Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=LENZ&period=max&api_key=YOUR_API_KEY